Business Wire06.08.18
New Zealand biomedical company Aroa Biosurgery and U.S. medical products company Hydrofera are launching Appulse in North America.
The two companies have recently bought back their wound care businesses from Hollister Inc.
Brian Ward, CEO of Aroa Biosurgery, says the company’s Endoform wound care technology and Hydrofera Blue are complementary. “We have both been successfully represented by Hollister, but with Hollister’s decision to divest portions of its wound care business back to the technology developers, it gives us the opportunity to now grow the businesses ourselves,” he said.
Tom Drury, CEO of Hydrofera, added, “Most of the Hollister sales team for Endoform and Hydrofera Blue will continue to represent both products. This will help ensure the same level of service to patients, clinicians and distribution partners.”
Endoform is a proprietary extracellular matrix (ECM) biomaterial, which contains a collagen scaffold and important secondary molecules to support healing.
Endoform Dermal Template was launched in the United States in 2013 for the treatment of acute and chronic wounds after obtaining U.S. Food and Drug Administration clearance. Since then, Endoform has become established as a leading product for treating diabetic and venous ulcers and been used in more than 2.5 million treatments.
Hydrofera LLC produces a line of antibacterial wound dressings, utilizing its proprietary PVA and polyurethane foam technology in combination with two natural organic pigments. This combination of two technology platforms yields a line of advanced wound dressings that improve patient outcomes and lower treatment costs.
Aroa is a private, venture funded soft-tissue repair company that develops and manufactures medical products to improve healing. Its products are developed from the Endoform platform, a novel extracellular matrix biomaterial.
Hydrofera LLC, is owned by a group of investors led by Tom Drury, one of the founders of Hydrofera Blue products. The company develops and manufactures Polyvinyl Alcohol (PVA) foam products for medical applications. Headquartered in Manchester, Conn., Hydrofera LLC serves customers in the United States and Canada with its portfolio of Hydrofera Blue products.
The two companies have recently bought back their wound care businesses from Hollister Inc.
Brian Ward, CEO of Aroa Biosurgery, says the company’s Endoform wound care technology and Hydrofera Blue are complementary. “We have both been successfully represented by Hollister, but with Hollister’s decision to divest portions of its wound care business back to the technology developers, it gives us the opportunity to now grow the businesses ourselves,” he said.
Tom Drury, CEO of Hydrofera, added, “Most of the Hollister sales team for Endoform and Hydrofera Blue will continue to represent both products. This will help ensure the same level of service to patients, clinicians and distribution partners.”
Endoform is a proprietary extracellular matrix (ECM) biomaterial, which contains a collagen scaffold and important secondary molecules to support healing.
Endoform Dermal Template was launched in the United States in 2013 for the treatment of acute and chronic wounds after obtaining U.S. Food and Drug Administration clearance. Since then, Endoform has become established as a leading product for treating diabetic and venous ulcers and been used in more than 2.5 million treatments.
Hydrofera LLC produces a line of antibacterial wound dressings, utilizing its proprietary PVA and polyurethane foam technology in combination with two natural organic pigments. This combination of two technology platforms yields a line of advanced wound dressings that improve patient outcomes and lower treatment costs.
Aroa is a private, venture funded soft-tissue repair company that develops and manufactures medical products to improve healing. Its products are developed from the Endoform platform, a novel extracellular matrix biomaterial.
Hydrofera LLC, is owned by a group of investors led by Tom Drury, one of the founders of Hydrofera Blue products. The company develops and manufactures Polyvinyl Alcohol (PVA) foam products for medical applications. Headquartered in Manchester, Conn., Hydrofera LLC serves customers in the United States and Canada with its portfolio of Hydrofera Blue products.